Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Catastrophic Retroperitoneal Hemorrhage in Covid-19 Patients Under Anticoagulant Prophylaxis Publisher



Javid A1 ; Kazemi R2 ; Dehghani M3, 4 ; Bahrami Samani H3, 4
Authors

Source: Urology Case Reports Published:2021


Abstract

COVID-19 patients are at high risk for both capillary micro thrombi and large vessel thrombosis. Anticoagulant administration in COVID-19 patients, especially in ICU setting, is recommended by some researchers. However, clinical guidelines don't yet recommend anticoagulation therapies in therapeutic doses in these patients. In this article, we try to introduce a less known complication of heparin application in COVID-19 patients. Retroperitoneal hemorrhage when involves the psoas muscle might be deadly because of the large volume of bleeding before causing any significant alarm. It is very important to be careful in diagnosing and managing this complication. © 2021
Other Related Docs
4. Anticoagulant Therapy During Cardiopulmonary Bypass, Journal of Thrombosis and Thrombolysis (2008)
6. Covid-19 Pneumonia and Pulmonary Embolism: Presentation of Four Cases, Indian Journal of Critical Care Medicine (2020)
12. Thrombocytopenia and Coronavirus: A Prognosis and Progression of the Coronavirus Disease, Iranian Journal of Pediatric Hematology and Oncology (2022)
15. Anticoagulation Therapy in Covid-19 Patients With Chronic Kidney Disease, Journal of Research in Medical Sciences (2021)